NASDAQ:ZNTL

Zentalis Pharmaceuticals Stock News

*Your capital is at risk

$4.74

-0.180 (-3.66%)

At Close: Jul 31, 2026

Why Earnings Season Could Be Great for Zentalis (ZNTL)

09:50am, Thursday, 04'th Feb 2021

Zentalis (ZNTL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

featured in The Global Fintech Index 2020 as the top Fintech company of the country.